Barnes Wealth Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Buy
15,391
+795
+5% +$20.8K 0.17% 124
2026
Q1
$410K Buy
14,596
+1,786
+14% +$47.5K 0.21% 109
2025
Q4
$319K Sell
12,810
-3,320
-21% -$83.7K 0.17% 118
2025
Q3
$411K Sell
16,130
-21
-0.1% -$518 0.23% 97
2025
Q2
$392K Buy
16,151
+33
+0.2% +$770 0.23% 95
2025
Q1
$408K Buy
16,118
+1,828
+13% +$47.8K 0.26% 90
2024
Q4
$379K Buy
+14,290
New +$388K 0.25% 88

Other funds holding PFE

Barnes Wealth Management Group's PFE Position: Q2 2026 in Review

Barnes Wealth Management Group increased its Pfizer (PFE) stake by 5.4% in Q2 2026, buying an estimated $20.8K and bringing the position to 15,391 shares worth $371K. The position accounts for 0.17% of the portfolio, ranked #124.

Barnes Wealth Management Group first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $411K in Q3 2025. 1,005 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Barnes Wealth Management Group held 15,391 shares of Pfizer worth $371K as of Q2 2026.
  • Barnes Wealth Management Group bought 795 Pfizer shares in Q2 2026, an estimated $20.8K.
  • Pfizer made up 0.17% of Barnes Wealth Management Group's portfolio in Q2 2026, its #124 holding.
  • Barnes Wealth Management Group first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Barnes Wealth Management Group's Pfizer position peaked at $411K in Q3 2025.
  • 1,005 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Barnes Wealth Management Group's 13F filing for Q2 2026, filed 24 Jul 2026.